Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ivan Cruz-Esquivel"'
Autor:
Tatiana Galicia-Carmona, Eder Arango-Bravo, Juan a Serrano-Olvera, Celia Flores-de La Torre, Ivan Cruz-Esquivel, Ricardo Villalobos-Valencia, Andrés Morán-Mendoza, Denisse Castro-Eguiluz, Lucely Cetina-Pérez
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 8, Pp 2617-2625 (2021)
Human papillomavirus (HPV) infection is a well-known cause of cervical cancer. Therapeutic cancer vaccines are part of the current therapeutic options for HPV-associated cancers. Axalimogen filolisbac (ADXS11-001) is an immunotherapy based on live at
Externí odkaz:
https://doaj.org/article/3872b6f340e5468fa49351ddbfd1ad01
Autor:
Ivan Cruz-Esquivel, Celia Flores-de la Torre, Tatiana Galicia-Carmona, Juan Alberto Serrano-Olvera, Andrés Morán-Mendoza, Eder Arango-Bravo, Denisse Castro-Eguiluz, Lucely Cetina-Pérez, Ricardo Villalobos-Valencia
Publikováno v:
Hum Vaccin Immunother
Human papillomavirus (HPV) infection is a well-known cause of cervical cancer. Therapeutic cancer vaccines are part of the current therapeutic options for HPV-associated cancers. Axalimogen filolisbac (ADXS11-001) is an immunotherapy based on live at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86c5f51a7f97c35f2f4ec4a652f13a88
https://europepmc.org/articles/PMC8475562/
https://europepmc.org/articles/PMC8475562/